한글목차

여성용 건강 진단 동향 및 전망

세계 여성용 건강 진단 시장의 미래는 병원 및 클리닉, 진단 및 영상 센터, 재택 의료 시장에서 기회가 있을 것으로 예상됩니다. 세계 여성 건강 진단 시장은 2024년부터 2030년까지 7.2%의 CAGR로 2030년까지 약 377억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 PoC(Point of Care) 검사 및 신속 진단 검사에 대한 선호도 증가와 유방암, 난소암, HIV와 같은 만성질환을 앓고 있는 여성들의 증가입니다.

• Lucintel은 유형별로는 진단 검사가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상하고 있습니다.
• 암, 감염, 골다공증, 임신, 불임 검사 등의 치료를 위해 병원이나 클리닉을 선호하는 여성이 증가함에 따라 최종 용도별로는 병원과 클리닉이 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 암에 걸린 여성의 증가와 주요 진단약 제조업체의 존재로 인해 북미가 여전히 가장 큰 지역입니다.

여성용 건강 진단 시장의 전략적 성장 기회

여성용 건강 진단 시장은 기술 발전과 의료 수요의 변화로 인해 다양한 용도에 걸쳐 다양한 전략적 성장 기회를 제공하고 있습니다.

• 유전자 및 유전체 검사의 확대 : 첨단 유전자 및 유전체 검사의 개발이 진행되고 있습니다. 이러한 검사는 유전적 위험을 식별하고 치료를 조정하여 개인화된 건강 관리를 원하는 오늘날의 의료 소비자들이 원하는 솔루션을 제공할 수 있습니다.
• 원격의료 진단의 성장 : 원격 진단을 위한 원격의료 플랫폼과 도구에 대한 투자는 편의성과 접근성 요구를 충족시키는 가상 진료 및 원격 모니터링 솔루션을 통해 의료 서비스 접근의 격차를 해소할 수 있는 길을 제공합니다.
• AI 기반 진단의 발전 : AI 진단학은 영상 진단 및 데이터 분석의 지속적인 발전으로 비약적인 잠재력을 계속 보여주고 있습니다. 진단 효율을 높이고 정확도를 향상시키는 알고리즘을 개발하는 것은 치료 결과를 개선하고 시장 리더의 지위를 유지하는 데 핵심적인 역할을 합니다.
• 분자진단 도구 개발 : 차세대 시퀀서 개발 및 바이오마커 식별을 통해 많은 시장 기회가 창출될 것입니다. 이러한 도구는 병태생리를 조기에 발견하고, 보다 구체적인 치료를 가능하게 하며, 환자 관리를 개선할 수 있도록 돕습니다.
• 예방 검진 프로그램 확대 : 유방암 및 자궁경부암과 같은 예방 검진 프로그램의 확대는 성장과 실행의 잠재적인 길입니다. 이러한 프로그램은 특정 질병의 발생률을 낮추고, 국민 건강을 개선하며, 이러한 진단 서비스에 대한 수요를 증가시킬 수 있습니다.

이러한 새로운 기회는 새로운 유전자 검사법, 원격의료 플랫폼, AI 기반 진단, 분자 도구, 예방적 검진 등을 통해 실현될 수 있습니다. 이러한 기회를 활용하면 여성 건강 검진 시장의 혁신과 확장을 유도하고 다양한 건강 결과에 대한 치료를 강화하여 양질의 치료를 보장할 수 있습니다.

여성용 건강 진단 시장의 촉진요인 및 과제

여성용 건강 진단 시장은 기술 개발, 경제적 요인, 규제 변화를 반영하여 몇 가지 촉진요인과 과제가 존재합니다.

여성용 건강 진단 시장을 주도하는 요인은 다음과 같습니다.

• 기술 발전 : AI, 분자진단, 원격의료 등 진단기술의 혁신이 시장 촉진요인으로 작용하고 있습니다. 진단 기술의 발전은 더 높은 진단 성능, 더 높은 효율성, 더 나은 치료 접근성으로 이어집니다.
• 건강에 대한 인식의 증가 : 최근 몇 년 동안 건강 인식이 높아지면서 고부가가치 진단 솔루션에 대한 수요가 증가하고 있습니다. 질병의 조기 진단과 건강 관리에 대한 관심이 높아지면서 매우 개인적 관심도 높아지고 있습니다.
• 개인화 의료에 대한 수요 증가 : 개인화 의료는 유전자 검사 및 유전체 검사를 통해 치료를 촉진함으로써 표적화된 진단 솔루션을 제공하는 새로운 경로를 제공합니다. 개인화된 접근 방식은 치료 결과를 개선하고 환자 만족도를 높일 수 있습니다.
• 원격의료 서비스 확대 : 원격의료 서비스는 특히 의료 서비스가 부족한 지역으로 진단 진료를 확대하고 있습니다. 원격진료 및 진단은 편리함과 의료에 대한 더 나은 접근성을 제공합니다.
• 예방 의료에 대한 강조 : 예방 의료와 조기 발견에 대한 중요성이 점점 더 강조되고 있으며, 진단 검사 및 진단 도구의 도입이 증가하고 있습니다. 예방은 여성의 건강을 효과적으로 관리하기 위한 필수적인 요소가 되고 있습니다.

여성용 건강 진단 시장의 과제는 다음과 같습니다.

• 첨단 기술의 높은 비용 : 첨단 진단 기술 및 유전자 검사에는 비용이 많이 듭니다. 비용 상승은 일부 사람들의 접근을 계속 제한하고 시장 성장을 저해할 수 있습니다.
• 규제 및 컴플라이언스 문제 : 규제 요건을 충족하고 건강 및 안전 표준을 준수해야 합니다. 일부 규제 장벽은 새로운 진단 솔루션의 개발 및 활용 가능성에 영향을 미칠 수 있습니다.
• 데이터 프라이버시 우려 : 민감한 건강 데이터의 수집과 활용은 특히 디지털 플랫폼과 원격의료 플랫폼에서 프라이버시 및 보안에 대한 우려를 낳는다. 이는 데이터 보호와 프라이버시 우려에 대한 책임이라는 두 가지 중요한 과제를 해결해야 합니다.

여성용 건강 진단 시장의 촉진요인으로는 기술 발전, 건강 인식의 향상, 맞춤형 의료에 대한 수요, 원격의료의 확대, 예방 의료의 중요성 등이 있습니다. 그러나 높은 비용, 규제 준수 필요성, 데이터 프라이버시에 대한 우려 등의 문제도 여전히 남아 있습니다. 이러한 상호 요인은 시장 역학 형성에 기여하고 성장 경로에 영향을 미칠 것입니다.

목차

제1장 주요 요약

제2장 세계의 여성용 건강 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 여성용 건강 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 여성용 건강 진단 시장 : 종류별
  • 부속품·소모품
  • 진단 검사
  • 진단 장비
• 세계의 여성용 건강 진단 시장 : 최종 용도별
  • 병원·진료소
  • 진단·영상 진단 센터
  • 재택의료
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2030년)

• 세계의 여성용 건강 진단 시장 : 지역별
• 북미의 여성용 건강 진단 시장
• 유럽의 여성용 건강 진단 시장
• 아시아태평양의 여성용 건강 진단 시장
• 기타 지역의 여성용 건강 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 여성용 건강 진단 시장 성장 기회 : 종류별
  • 세계의 여성용 건강 진단 시장 성장 기회 : 최종 용도별
  • 세계의 여성용 건강 진단 시장 성장 기회 : 지역별
• 세계의 여성용 건강 진단 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 여성용 건강 진단 시장 생산능력 확대
  • 세계의 여성용 건강 진단 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Siemens Healthcare
• Hologic
• GE Healthcare
• F.Hoffmann-La Roche
• Koninklijke Philips

영문목차

Women Health Diagnostic Trends and Forecast

The future of the global women health diagnostic market looks promising with opportunities in the hospital and clinic, diagnostic and imaging center, and homecare markets. The global women health diagnostic market is expected to reach an estimated $37.7 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are a rising preference for point-of-care and rapid diagnostic tests, and an increasing number of women developing chronic diseases such as breast cancer, ovarian cancer, and HIV.

• Lucintel forecasts that, within the type category, diagnostic test is expected to witness the highest growth over the forecast period.
• Within the end-use category, hospitals and clinics will remain the largest segment due to rising women's preference towards this facility for the treatment of cancer, infectious disease, osteoporosis, pregnancy, and fertility testing.
• In terms of region, North America will remain the largest region due to the rising number of cancer-affected women and the presence of key diagnostics product manufacturers in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Women Health Diagnostic Market

Key trends are increasingly influencing the women's health diagnostic market, fundamentally changing how diagnostics are approached and delivered.

• AI and Machine Learning Integration: The increasing integration of artificial intelligence and machine learning in diagnostic imaging and data analysis is improving accuracy and efficiency. AI algorithms can analyze complex medical images and patient data more quickly than previous methods, leading to quicker and more accurate diagnoses.
• Personalized Diagnostics: There is an increasing trend toward personalized medicine, with diagnostic tests aimed at specific genetic and health profiles. This makes detection and treatment both more precise and effective, according to the particular genetic profile of each individual.
• Telemedicine and Remote Diagnostics: Telemedicine is expanding diagnostic services to patients who are distant from specialized consulting. These remote diagnostic tools are becoming increasingly sophisticated, allowing for earlier detection and follow-up of conditions without the need for physical visits.
• Advanced Molecular Diagnostics: The use of molecular diagnostics, including genomics and proteomics, is being increasingly applied for the identification of biomarkers associated with diseases. These technologies can achieve early detection, even to the point of targeted treatment, improving patient outcomes.
• Emphasis on Preventive Health: There is growing interest in diagnosing health conditions earlier before they reach severe stages. Hence, screening programs and technologies that enable early detection are becoming integral to managing women's health and making the care delivered more proactive than curative.

These are the trends that will revolutionize the women's health diagnostics market by improving accuracy through artificial intelligence, offering customized solutions, increasing access through telemedicine, providing better early detection through molecular diagnostics, and focusing on preventive care. The integration of such elements will lead to more effective diagnostic solutions for women's health.

Recent Developments in the Women Health Diagnostic Market

Recent key developments in the women's health diagnostic market indicate advancements in technology and improvements in diagnostic capabilities.

• AI-Driven Diagnostic Tools: With the introduction of AI-driven diagnostic tools, the bar has been set high for imaging and data analysis accuracy. These tools support the early detection of conditions such as breast cancer, enabling diagnostics to be more precise and leading to improved patient outcomes.
• Genetic Testing Expansion: Genetic testing has become much more accessible, making it possible to detect hereditary conditions well in advance. This allows for the selection of appropriate treatment programs, supporting targeted therapies, and enhancing diagnostic accuracy.
• Integration of Telehealth: With the integration of telehealth services into diagnostics, access to care has expanded by offering remote consultations and diagnostic assessments. This development is particularly useful in locations where access to healthcare services is limited and for individuals seeking convenience.
• Advancements in Molecular Diagnostics: Advanced molecular diagnostics, such as next-generation sequencing and proteomics, represent recent developments in biomarker detection. These advancements provide a deeper understanding of disease mechanisms, leading to more tailored and effective treatments.
• Focus on Preventive Screenings: There is now a greater emphasis on conducting preventive screenings for diseases such as breast and cervical cancer. Early detection through these screenings helps reduce incidence and improve outcomes through timely interventions.

These developments are further complementing the market for women's health diagnostics by improving diagnostic accuracy, providing access to genetic and telehealth services, advancing molecular diagnostics, and promoting preventive screenings. Collectively, these factors are driving better and more comprehensive diagnostics for women.

Strategic Growth Opportunities for Women Health Diagnostic Market

The women's health diagnostic market presents various strategic growth opportunities across different applications, driven by technological advances and changing healthcare needs.

• Expansion of Genetic and Genomic Testing: There is a development of advanced genetic and genomic testing offerings. These tests can identify hereditary risks and tailor treatments to provide solutions demanded by today's healthcare consumers seeking personalized health management.
• Growth in Telehealth Diagnostics: Investment in telehealth platforms and tools for remote diagnosis provides an avenue to bridge the gaps in accessing care through virtual consultations and remote monitoring solutions that meet the needs for convenience and access.
• Advancements in AI-Based Diagnostics: AI diagnostics continue to show exponential opportunities, with ongoing development in image diagnostics and data analysis. Developing algorithms for enhanced diagnostic efficiency and improved accuracy will be key to enhancing outcomes and ensuring that the status of market leaders is maintained.
• Development of Molecular Diagnostic Tools: Many opportunities in the market will arise from the development of next-generation sequencing and the identification of biomarkers. These tools have made it possible to detect conditions at an early stage, enabling more specific treatments and leading to better patient management.
• Expansion of Preventive Screening Programs: Expanding preventive screening programs for diseases such as breast and cervical cancer is a potential avenue for growth and implementation. These programs help reduce the incidence of certain conditions, improving the health of the population and increasing demand for these diagnostic services.

Some of these emerging opportunities will be realized through new genetic testing methods, telehealth platforms, AI-based diagnostics, molecular tools, and preventive screenings. Adopting such opportunities can trigger innovations and expansions in the women's health diagnostic market, enhancing the treatment of diverse health outcomes and ensuring high-quality care.

Women Health Diagnostic Market Driver and Challenges

Several drivers and challenges mark the terrain of the women's health diagnostic market, reflecting shifts in technological development, economic factors, and regulatory considerations.

The factors responsible for driving the women's health diagnostic market include:

• Technological advancements: Innovation in diagnostic technologies, including AI, molecular diagnostics, and telehealth, creates market drivers. Improvements in diagnostic technologies lead to higher diagnostic performance, greater efficiency, and better access to care.
• Rising health awareness: Improved health awareness in recent years has, in turn, raised demand for high-value diagnostic solutions. Increased focus on early disease diagnosis and health management is highly personal.
• Growing demand for personalized medicine: Personalized medicine-the facilitation of treatments through genetic and genomic testing-provides new avenues for offering targeted diagnostic solutions. Treatment outcomes improve with personalized approaches, and patients are more satisfied.
• Expansion of telehealth services: Telehealth services are expanding diagnostic care, particularly into underserved areas. Remote consultations and diagnostics offer convenience and better access to healthcare.
• Focus on preventive health: With increasing emphasis on preventive health and early detection, diagnostic screenings and tools are being adopted. Prevention is gradually becoming an intrinsic element in managing women's health effectively.

Challenges in the women's health diagnostic market include:

• High costs of advanced technologies: Advanced diagnostic technologies and genetic testing are costly. Higher costs will continue to limit access for some populations and may hinder growth in the market.
• Regulatory and compliance issues: There is a need to address regulatory requirements and ensure compliance with health and safety standards. Some regulatory barriers may impact the development and availability of new diagnostic solutions.
• Data privacy concerns: The collection and utilization of sensitive health data create privacy and security concerns, especially about digital and telehealth platforms. This addresses two critical challenges: ensuring data protection and taking responsibility for privacy concerns.

The drivers for the women's health diagnostics market include technological advances, increased health awareness, demand for personalized medicine, expansion of telehealth, and an emphasis on preventive health. Yet, challenges remain in terms of high costs, the need for regulatory compliance, and data privacy concerns. These mutual factors contribute to shaping market dynamics and thus influence the growth path.

List of Women Health Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies women health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the women health diagnostic companies profiled in this report include-

• Siemens Healthcare
• Hologic
• GE Healthcare
• F.Hoffmann-La Roche
• Koninklijke Philips

Women Health Diagnostic by Segment

The study includes a forecast for the global women health diagnostic by type, end use, and region.

Women Health Diagnostic Market by Type [Analysis by Value from 2018 to 2030]:

• Accessories & Consumables
• Diagnostic Tests
• Diagnostic Devices

Women Health Diagnostic Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Diagnostic and Imaging Centers
• Homecare
• Others

Women Health Diagnostic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Women Health Diagnostic Market

The women's health diagnostic market is highly dynamic, characterized by constant and rapid developments driven by technological breakthroughs in health information and changing health needs. This represents a global effort toward solving very specific health issues, while also improving diagnostic accuracy for women. Different countries are engaging in various efforts, ranging from advanced screening technologies to personalized health solutions.

• United States: Advanced diagnostic equipment, including AI-driven imaging and genomics-based tests for women's health, is under development in the U.S., with a greater focus on personalized medicine and early detection of diseases related to breast and ovarian cancer. The integration of digital health platforms has also increased access to diagnostic services, thereby improving patient management.
• China: The women's health diagnostics market in China is rapidly developing, with a focus on integrating advanced imaging and expanding screening programs. Recently, there has been easier access to genetic testing and improvements in reproductive health diagnostics. The current focus is on using big data and AI to enhance diagnostic precision and accessibility.
• Germany: Germany is making progress in the diagnosis of women's health by combining precision medicine with advanced imaging technologies. The market is seeing more applications of molecular diagnostics and biomarkers to create personalized treatments. Germany is also promoting preventive diagnostics and early detection, supported by its strong healthcare and research infrastructure.
• India: Affordable diagnostic solutions and mobile health technologies are among the recent developments aimed at improving healthcare accessibility for women in India. The government is now developing plans to expand cancer and reproductive health screening programs through public health initiatives, supported by advancements in low-cost diagnostic technologies.
• Japan: Innovations in early detection and preventive technologies are key drivers in the women's health diagnostics market in Japan. The country has also seen developments in minimally invasive diagnostic procedures and the integration of AI in imaging. Additionally, Japan focuses on comprehensive screening programs and personalized health management to address women's health issues effectively.

Features of the Global Women Health Diagnostic Market

Market Size Estimates: Women health diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Women health diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Women health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the women health diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the women health diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the women health diagnostic market by type (accessories & consumables, diagnostic tests, and diagnostic devices), end use (hospitals and clinics, diagnostic and imaging centers, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Women Health Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Women Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Women Health Diagnostic Market by Type
  • 3.3.1: Accessories & Consumables
  • 3.3.2: Diagnostic Tests
  • 3.3.3: Diagnostic Devices
• 3.4: Global Women Health Diagnostic Market by End Use
  • 3.4.1: Hospitals and Clinics
  • 3.4.2: Diagnostic and Imaging Centers
  • 3.4.3: Homecare
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Women Health Diagnostic Market by Region
• 4.2: North American Women Health Diagnostic Market
  • 4.2.1: North American Market by Type: Accessories & Consumables, Diagnostic Tests, and Diagnostic Devices
  • 4.2.2: North American Market by End Use: Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, and Others
• 4.3: European Women Health Diagnostic Market
  • 4.3.1: European Market by Type: Accessories & Consumables, Diagnostic Tests, and Diagnostic Devices
  • 4.3.2: European Market by End Use: Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, and Others
• 4.4: APAC Women Health Diagnostic Market
  • 4.4.1: APAC Market by Type: Accessories & Consumables, Diagnostic Tests, and Diagnostic Devices
  • 4.4.2: APAC Market by End Use: Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, and Others
• 4.5: ROW Women Health Diagnostic Market
  • 4.5.1: ROW Market by Type: Accessories & Consumables, Diagnostic Tests, and Diagnostic Devices
  • 4.5.2: ROW Market by End Use: Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Women Health Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Women Health Diagnostic Market by End Use
  • 6.1.3: Growth Opportunities for the Global Women Health Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Women Health Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Women Health Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Women Health Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthcare
• 7.2: Hologic
• 7.3: GE Healthcare
• 7.4: F.Hoffmann-La Roche
• 7.5: Koninklijke Philips